Cargando…
Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption
BACKGROUND: Psilocybin, the primary psychoactive component of psychedelic ‘magic mushrooms’, may have potential for treating depressive symptoms, and consequent applications for bipolar disorder (BD). Knowledge of the risks and benefits of psilocybin in BD is limited to case studies. AIM: To support...
Autores principales: | Morton, Emma, Sakai, Kimberly, Ashtari, Amir, Pleet, Mollie, Michalak, Erin E, Woolley, Josh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834328/ https://www.ncbi.nlm.nih.gov/pubmed/36515370 http://dx.doi.org/10.1177/02698811221131997 |
Ejemplares similares
-
“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use
por: DellaCrosse, Meghan, et al.
Publicado: (2022) -
S‐Adenosyl‐l‐Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms
por: Demmler, Richard, et al.
Publicado: (2020) -
Psilocybin: the magic medicine for depression?
por: Corrigan, Amber Elyse, et al.
Publicado: (2021) -
Simultaneous Production of Psilocybin and a Cocktail of β‐Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms
por: Blei, Felix, et al.
Publicado: (2019) -
Will psilocybin lose its magic in the clinical setting?
por: Hayes, Caroline, et al.
Publicado: (2022)